Login / Signup

Complete withdrawal is the most effective approach to reduce disability in patients with medication-overuse headache: A randomized controlled open-label trial.

Mia NielsenLouise Ninett CarlsenSigne Bruun MunksgaardIda Maria Storm EngelstoftRigmor Højland JensenLars Bendtsen
Published in: Cephalalgia : an international journal of headache (2019)
Clinicaltrials.gov (NCT02903329).
Keyphrases
  • open label
  • phase iii
  • phase ii
  • study protocol
  • clinical trial
  • multiple sclerosis
  • phase ii study
  • healthcare
  • randomized controlled trial
  • adverse drug
  • double blind
  • squamous cell carcinoma